• Mashup Score: 0

    July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR) leadless pacemaker system, the world’s first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms. With more than 80% of people who need a pacemaker requiring pacing in two chambers of the heart (both the right atrium and right ventricle),…

    Tweet Tweets with this article
    • @DAICeditor @AbbottCardio #Leadless #pacemakers provide a new minimally invasive option that will #revolutionize care for more people in the U.S. who need pacing to treat a variety of slow or abnormal #heartrhythms: https://t.co/9G12urHw7A

  • Mashup Score: 0

    May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device Exemption (IDE) study, a large-scale study to assess the world’s first dual-chamber leadless pacemaker, showing that the leadless pacemaker met its three prespecified primary endpoints for safety and performance. The data further suggests that AVEIR DR could offer new benefits for…

    Tweet Tweets with this article
    • @DAICeditor @AbbottCardio Abbott's #AVEIR DR i2i IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber #leadless #pacemaker: https://t.co/iqHX5lv4Ef #HRS23

  • Mashup Score: 0

    May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization therapy (CRT) among patients who were not able to be treated with conventional CRT and epicardial leads. The novel WiSE CRT system removes the possibility of lead complications and provides physicians with more freedom to target the pacing site within the endocardium of the…

    Tweet Tweets with this article
    • @DAICeditor Results from a pivotal clinical trial found a #leadless #pacemaker can deliver #cardiac #resynchronization therapy (#CRT) among patients who were not able to be treated with conventional CRT and #epicardial leads: https://t.co/MEi8YZvONP #HRS23

  • Mashup Score: 0

    May 1, 2023 — Medtronic plc, a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers.  Micra AV2 and Micra VR2, the world’s smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers,…

    Tweet Tweets with this article
    • @DAICeditor @Medtronic Medtronic announced it has received #FDA approval of its #Micra_AV2 and #Micra_VR2, the next generation of its industry-leading miniaturized, #leadless #pacemakers: https://t.co/v5FSLSAoaq

  • Mashup Score: 0

    April 13, 2023 — Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal of the American Heart Association.  Children with a heartbeat that is too slow (bradycardia) require pacemakers — devices…

    Tweet Tweets with this article
    • @DAICeditor @American_Heart This study provides the first data on #leadless #pacemakers in a #pediatric population in a real-world setting: https://t.co/bEeAQ2CSJu #bradycardia #HeartFailure

  • Mashup Score: 2

    September 13, 2022 — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient, ŌNŌCOR LLC announced. The team at UCLA Medical Center, Los Angeles, California, percutaneously removed the wayward device from the patient using a combination of ŌNŌ, commercially available…

    Tweet Tweets with this article
    • @DAICeditor @ONOCORvascular The #ŌNŌ #endovascular retrieval system was recently used to remove a #malpositioned #leadless #pacemaker (#LPM) that #embolized to the #right_pulmonary_artery in a 52- year-old patient, ŌNŌCOR LLC announced: https://t.co/fCXvd7t2GL

  • Mashup Score: 0

    The history of bioelectronic medicine (BM) in cardiology is a tiara studded with emerald innovators, animated by impellent clinical needs. John ‘Jack’ Hopps, an

    Tweet Tweets with this article
    • Bioelectronic medicine in cardiology: an endless tale! Look at the paths of improvement for bioelectronic medicine in cardiology! #loop #device #miniaturization #cardiac #leadless #pacing #EHJ #cardiotwitter @ESC_Journals @escardio https://t.co/O4MKBWYbGd https://t.co/DI4DbkdQeS